Human & Experimental Toxicology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gawarammana, I B
Right arrow Articles by Jones, A L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gawarammana, I B
Right arrow Articles by Jones, A L
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Human & Experimental Toxicology, Vol. 25, No. 11, 645-649 (2006)
DOI: 10.1177/0960327106074594
© 2006 SAGE Publications

Should all patients with unexplained anaemia be screened for chronic lead poisoning?

I B Gawarammana

Guy's and St Thomas' Poisons Unit, Medical Toxicology Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK; Medical Toxicology Unit, Guy's and St Thomas' NHS Trust, Avonley Road, SE14 5ER, London, UK indika.gawarammana{at}gstt.nhs.uk;indikagawarammana@yahoo.com

P I Dargan

Guy's and St Thomas' Poisons Unit, Medical Toxicology Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK

S Woodcock

M Sculley

Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK

I M House

D M Wood

A L Jones

Guy's and St Thomas' Poisons Unit, Medical Toxicology Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK

The global prevalence of lead poisoning is declining. However, the prevalence of lead poisoning in patients with either microcytic or normocytic anaemia is unknown. Blood samples from anaemic patients residing in south-east London without an obvious cause for anaemia had their blood lead concentration (BLC) analysed.A batch of 988 samples was analysed for BLC using atomic absorption spectroscopy. Median haemoglobin was 10.3 g/dL (range: 4.2–10.9) in females, 10.6 g/dL (range: 5.2–11.4) in males and 10.7 g/dL (range: 6.7–10.9) in children. Median BLC was 2.63 µg/dL (0.21–24.0 µg/dL; 95th centile 7.54 µg/dL). Fifteen samples (1.5%) had a BLC>10.0 µg/dL, five samples (1%)>15.0 µg/dL and one sample (0.1%)>20.0 µg/L. In the 106 children, median BLC was 2.34 µg/dL (0.5–14.5 µg/dL; 95th centile 6.12 µg/ dL). Only one child (14.5 µg/L) had a BLC>10.0 µg/dL. There was a poor correlation between haemoglobin and BLC (r2=0.08).Routine screening for lead poisoning cannot be justified in all patients with unexplained anaemia, unless there is a history or clinical features to suggest lead toxicity. Additionally, we have shown that in this former high-risk area for lead exposure, there is a low point prevalence of significant lead poisoning, even in an anaemic population.

Key Words: anaemia • epidemiology • lead • poisoning • screening


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?